Alkermes (ALKS) Net Cash Flow (2010 - 2026)
Alkermes (ALKS) posted quarterly Net Cash Flow of $160.0 million for Q2 2026, up 31.78% year-over-year from $121.4 million in Q2 2025, and up 120.82% quarter-over-quarter from -$768.2 million in Q1 2026.
Alkermes (ALKS) Net Cash Flow (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Net Cash Flow for 17 consecutive years, with $160.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Cash Flow rose 31.78% year-over-year to $160.0 million; the TTM figure through Jun 2026 stood at -$9.7 million (up 30.69% YoY), while the FY2025 annual figure was $828.6 million, up 598.21% from the prior year.
- Net Cash Flow advanced to $160.0 million in Q2 2026 per ALKS's latest filing, from -$768.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $503.3 million in Q4 2025 and bottomed at -$768.2 million in Q1 2026.
- Historically, Net Cash Flow has averaged $9.7 million across 5 years, with a median of $18.9 million in 2022.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 1333.9% — and 2026, when it plunged 807.0%.
- Alkermes' Net Cash Flow stood at $28.5 million in 2022, then sank by 767.14% to -$190.2 million in 2023, then jumped by 44.73% to -$105.1 million in 2024, then soared by 578.69% to $503.3 million in 2025, then sank by 68.22% to $160.0 million in 2026.
- Business Quant data shows ALKS's Net Cash Flow at $160.0 million in Q2 2026, -$768.2 million in Q1 2026, and $503.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.50 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 159.98 Mn |
| Jun 30, 2026 | 159.98 Mn |
| Mar 31, 2026 | -768.22 Mn |
| Mar 31, 2026 | -768.22 Mn |
| Dec 31, 2025 | 503.33 Mn |
| Dec 31, 2025 | 503.33 Mn |
| Sep 30, 2025 | 95.25 Mn |
| Sep 30, 2025 | 95.25 Mn |
| Jun 30, 2025 | 121.39 Mn |
| Jun 30, 2025 | 121.39 Mn |
| Mar 31, 2025 | 108.66 Mn |
| Mar 31, 2025 | 108.66 Mn |
| Dec 31, 2024 | -105.15 Mn |
| Dec 31, 2024 | -105.15 Mn |
| Sep 30, 2024 | -138.86 Mn |
| Sep 30, 2024 | -138.86 Mn |
| Jun 30, 2024 | 114.40 Mn |
| Jun 30, 2024 | 114.40 Mn |
| Mar 31, 2024 | -36.72 Mn |
| Mar 31, 2024 | -36.72 Mn |